MYOS Corporation Reports Additional Clinical Data on the Impact of Fortetropin on Lean Body Mass, Fat Mass and Muscle Size in Male Subjects. [I call BS.] http://ir.myoscorp.com/press-releases/detail/544 Company Publishes White Paper Entitled, "The Effect of Fortetropin on Muscle: Clinical effects on lean body mass, fat mass and muscle size; Implications for use and proposed mechanism of action."http://content.stockpr.com/myoscorp/db/Clinical+Trials/312/whitepaper/Myostatin-White-Paper.pdf As discussed in the white paper, the University of Tampa clinical trial was a double-blind, placebo-controlled trial which examined the effects of Fortetropin on skeletal muscle growth, lean body mass, strength, and power in recreationally trained individuals who rely heavily on satellite cell activation. Forty-five subjects were divided into placebo, 6.6g and 19.8g dosing arms of Fortetropin daily for a period of 12 weeks. Results demonstrated a statistically significant increase in both muscle thickness and lean body mass in subjects taking Fortetropin compared to placebo. Strength and power endpoints, as measured by bench press, leg press and Wingate power, significantly increased from baseline in all study groups. Additionally, a statistically significant decrease in fat mass in subjects in the 19.8 g arm was noted.